Patient Testimonials

Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences
Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences

Unveiling Proton Therapy: China Medical University Hospital Innovates Healthcare Promotion to Malaysia, Advancing New Southbound Medical Exchange and Expanding Successful Experiences o:p>/o:p> Proton therapy is an advanced particle radiation treatment for cancer. The Proton Therapy Center at China Medical University Hospital (CMUH), which began operations this year, is the first institution in central Taiwan to offer proton radiation therapy. The center has already treated several patients with positive outcomes. Notably, two patients with rectal cancer showed significant tumor shrinkage and are now proceeding with further treatments, including surgery. CMUH, as part of its New Southbound Policy initiative, is promoting the results and experiences of proton therapy in Malaysia, where it has sparked significant attention and lively discussions.o:p>/o:p> Third Year of the New Southbound Policy: CMUH Hosts Smart Health Transformation Forum in Malaysiao:p>/o:p> This is the third year CMUH has executed the Ministry of Health and Welfare's (MOHW) "New Southbound Medical Cooperation and Industry Development Plan." Led by Dr. Chih-Kun Huang, Superintendent of the Body Science & Metabolic Disorders International Medical Center at CMUH, a six-member team specializing in proton radiation, metabolic surgery, and reconstructive surgery traveled to Kuala Lumpur on the 17th. They hosted the “2024 Smart Health Transformation Forum – Proton Therapy & Metabolic Surgery & Plastic Surgery” in collaboration with International Medical University (IMU) of Malaysia, with which CMUH had signed a memorandum of understanding (MOU). The forum facilitated in-depth exchanges on advanced technologies and achievements, including proton therapy, with Malaysia’s academic and medical communities. Ms. Ling-Ying Wu, Principal Assistant Director of the Taipei Economic and Cultural Office in Malaysia, praised CMUH’s dedication to deepening partnerships with MOU institutions and recognized the hospital's significant efforts in fostering Taiwan-Malaysia medical exchanges. MOHW, therefore, entrusted CMUH with this critical task and promised continued support to move forward together.o:p>/o:p> Promoting Cutting-Edge Medical Innovations to Malaysia through New Southbound Exchangeso:p>/o:p> On the 17th, CMUH partnered with Malaysia’s IMU to co-host the “2024 Smart Health Transformation Forum – Proton Therapy & Metabolic Surgery & Plastic Surgery” in Kuala Lumpur. Participants included prominent medical figures: Ms. Ling-Ying Wu (3rd from the right), Dr. Chih-Kun Huang (5th from the right), Dr. Jian-Jr Lee, Vice Superintendent of the CMU Central Taiwan Healthcare System and Director of the Department of Plastic and Reconstructive Microsurgery Surgery, CMUH (2nd from the right), Dr. Chun-Ru Chien, Director of the Division of Particle Therapy, CMUH (6th from the right), Dr. Shyun-Jing Wee, Attending Physician of the Department of Plastic and Reconstructive Microsurgery Surgery, CMUH (1st from the right), CEO Ai-Chi Chou, Executive Director of the International Medical Center, CMUH (7th from the right), and Professor Wong Shew Fung, Associate Director of Research and Innovation at IMU (4th from the right).o:p>/o:p> Taiwan’s Latest Proton Therapy Center: Minimizing Damage to Healthy Tissue, Shrinking Rectal Cancer Tumors without Major Side Effectso:p>/o:p> The Proton Therapy Center at CMUH is the newest of Taiwan’s four centers, equipped with 360-degree precise positioning and integrated with surgery, immunotherapy, cellular therapy, and one-stop international medical services to provide high-quality treatments. Dr. Chun-Ru Chien, Director of the Division of Particle Therapy at CMUH, noted that mid-stage rectal cancer often requires preoperative pelvic radiation therapy to shrink the tumor for subsequent surgery. However, pelvic radiation can lead to mild but common digestive and urinary side effects. Proton therapy, by contrast, is expected to significantly reduce the incidence of these side effects. Unlike photon radiation therapy, proton therapy minimizes unnecessary radiation to surrounding healthy tissue, thus reducing side effects. It is suitable for treating tumors throughout the body, especially those located in sensitive areas or near vital organs, such as brain tumors, head and neck cancers, breast cancer, lung cancer, esophageal cancer, liver cancer, prostate cancer, and recurrent tumors. It also holds promise for pediatric cancer patients, where it can reduce long-term complications, offering hope to more patients in need.o:p>/o:p> Robotic Minimally Invasive Surgery for Obesity: Precision Medicine Delivers Personalized Treatment Planso:p>/o:p> At the forum, Dr. Chih-Kun Huang, an expert in bariatric and metabolic surgery, shared the latest advancements and treatment philosophies. He emphasized that, in Malaysia, with the rising obesity rate, traditional treatments like lifestyle changes and medications are limited, creating an urgent need for innovative solutions. Recent advances in pharmacotherapy have introduced new anti-obesity drugs targeting appetite and energy balance. Additionally, bariatric surgery has seen the introduction of robotic minimally invasive surgery, and new insights into hormonal regulation of the gastrointestinal system have emerged. Precision medicine, including genetic and microbiome research, is also offering personalized treatment plans.o:p>/o:p> Stem Cells and Exosome Tissue Regeneration: A Breakthrough in Wound Healing Surpassing Traditional Methodso:p>/o:p> Dr. Jian-Jr Lee, Vice Superintendent of CMUH’s Fengyuan Branch and expert in plastic and reconstructive surgery, discussed the use of stem cells and exosomes in wound treatment. Stem cells possess the ability to differentiate into various cell types, making them crucial for tissue repair and regeneration. In wound healing, stem cells can transform into skin cells, blood vessels, and other essential components, accelerating recovery, reducing scarring, and improving outcomes for patients with chronic or complex wounds. Exosomes derived from stem cells stimulate cell proliferation, angiogenesis, and immune modulation, making exosome therapy a powerful tool in enhancing the body's natural healing mechanisms. CMUH fully leverages the regenerative potential of stem cells and the signaling properties of exosomes, achieving wound healing results that surpass traditional treatments.o:p>/o:p> Combining Super Microsurgery with 3D Printing: Precision Treatment for Head and Neck Cancer, Balancing Functionality and Aestheticso:p>/o:p> Dr. Shyun-Jing Wee, a plastic and reconstructive surgeon at CMUH, explained that CMUH’s reconstructive team has integrated super microsurgery with CAD/CAM and 3D printing technologies for head and neck cancer surgeries. These advancements allow for more precise tumor localization and treatment, offering personalized surgical options that optimize both functional and aesthetic outcomes, improving patients' quality of life.o:p>/o:p> Deepening Cooperation with New Southbound MOU Institutions: Expanding Successful Experiences and Enhancing Taiwan's Medical Brand Reputationo:p>/o:p> CEO Ai-Chi Chou, Executive Director of CMUH’s International Medical Center, stated that after signing an MOU with IMU in May, the hospital participated in the “2024 Next Generation of Care Conference” hosted by IMU, showcasing CMUH’s smart hospital technology in partnership with Wiicare and Wearable Wisdom (Keeogo). Datuk Dr. Muhammad Radzi bin Abu Hassan, Director-General of the Malaysian Ministry of Health, was highly impressed by the exhibition. This is the second collaboration between the two parties, focusing on CMUH’s cutting-edge medical innovations, including proton therapy, metabolic surgery, stem cells, exosomes, and super microsurgery. Through ongoing partnerships with MOU institutions, CMUH aims to build a foundation of trust and friendship, replicating its successful model across East Malaysia’s medical institutions and boosting the global reputation and favorability of Taiwan's medical brand. International Center / China Medical University Hospital(Taiwan) https://www.cmuh.cmu.edu.tw/Department/Detail_EN?depid=111 Tel:+886-4-22052121#12961~129641 E-mail:imc@tool.caaumed.org.tw o:p>/o:p>
【NUWA】A young Filipino with Polycystic Ovaries Underwent Successful Egg Retrieval and Graduated with a Pregnancy.
【NUWA】A young Filipino with Polycystic Ovaries Underwent Successful Egg Retrieval and Graduated with a Pregnancy.

Xiaomei from the Philippines was diagnosed with Polycystic Ovary Syndrome- one of the causes of infertility problems but she managed to overcome it and achieve her dream of becoming a mother. Dr. Pei-Chen Huang | NUWA Fertility Center A beautiful Young Filipino with Polycystic Ovaries was having trouble getting pregnant. Xiaomei from the Philippines has a petite figure, sweet and deep facial features, and a warm smile on her face. She had a typical "thin" polycystic case. Xiaomei's husband is a soldier and unlike most husbands who can go home for dinner every night, her husband only returns home once every ten days or half a month due to work demands. Xiao Mei was married in Taiwan and just wanted to have a baby as soon as possible so that she could have a companion in her daily life. During the first consultation, Dr. Huang tried using ovulation drugs for two months. Although Xiaomei’s husband was willing to accompany her for follow-up visits, the timing for her follicle tracking didn’t align with her husband’s days off, which left her feeling frustrated. Xiaomei wanted her husband to enjoy his day off instead of going with her and encouraged him to make the most of his holidays. They agreed that if they still hadn’t conceived in six months, they could return to see Dr. Huang for further medical support. Only two ovulation needles needed to harvest 12 good blastocysts Xiaomei and her husband then returned after 2 months of unsuccessful attempts. Although she was as sweet and smiling as usual, her words were full of helplessness. Since her husband would change the service camp to another country again in a few months, she firmly decided that she would directly use the IVF treatment this time to get pregnant as soon as possible! She said that it’s not easy to move from city to city let alone another island. During this period, Dr. Huang only used two ovulation injections, successfully retrieved 26 eggs, and froze 12 high-quality blastocysts. Since Xiaomei’s under 34 at that moment, she must rest for a month after egg retrieval. Then, a 5AA-grade blastocyst was implanted for the first time and needed to wait for another 10 days before doing a pregnancy test. When Dr. Huang followed up with Xiaomei after the wait, she announced to Xiaomei that she was finally Pregnant! That day was the first time Dr. Huang saw Xiaomei cry. Xiaomei’s husband was set to be deployed to another country the following week, which caused them both a lot of concerns. However, the good news they received from Dr. Huang lifted the weight of their worries, bringing a great sense of relief. The 5AA blastocyst was implanted and the pregnancy was completed. Later, Xiaomei’s mother-in-law who is Taiwanese, accompanied her for another implantation. She was a warm-hearted adult like her. She drove her back to the doctor and helped her with injections. The two of them looked very much like mother and daughter. Even though Dr. Huang and the staff already explained the medication and precautions to Xiaomei in English, her mother-in-law would always ask again to confirm because she was afraid of missing something. This time Dr. Huang implanted another 5AA blastocyst and because the blood clot number before and after implantation was high, they briefly used heparin. The baby finally settled in the mother's uterus smoothly. When everything was already stable, Xiaofen received graduation blessings from Dr. Huang before being transferred to the obstetrics department for follow-up care. “We only used two ovulation needles and received 12 blastocysts. Just imagine if we choose artificial insemination treatment, the risk of multiple births may not be small.” – said Dr. Huang. Young Women with PCOS Often Face Unexpected Pregnancies or Infertility. Taiwan Obstetrics and Gynecology Medical Association mentioned that polycystic ovary syndrome (PCOS) may cause metabolic dysfunction, hyperandrogenism, and fertility problems. The primary treatment options are lifestyle improvement and weight management. But did you know? PCOS varies among different ethnic groups! Due to differences in diet, genetics, environment, insulin resistance, obesity, and metabolic syndrome in women. Dr. Xiao Zhen has noticed that many young women with PCOS, despite having irregular periods, are often slim, have clear skin, and don't experience excessive hair growth. Women with polycystic ovary syndrome (PCOS) don’t completely stop ovulating. They may ovulate occasionally, but the timing is unpredictable, making it hard to track their ovulation period. Women with PCOS often face challenges when trying to conceive, and these difficulties should be addressed seriously. Women with polycystic ovaries are not in the minority, but the reasons for infertility are different in each case. It is recommended that you consult a professional reproductive physician. You are also welcome to consult with us online or directly in the clinic to help you tailor a good pregnancy treatment! Visit the largest fertility chain in Taiwan: https://www.nuwacare.com/en/ Follow Us on Facebook: https://www.facebook.com/NUWAFertilityCenter Contact us for consultation: ivfconsult@nuwacare.com

#Assisted Reproductive Technology
#Assisted Reproductive Technology#Medical Tourism
【NUWA】 Japanese Baby Made in Taiwan! - 40 Years Old Couple IVF Success Story
【NUWA】 Japanese Baby Made in Taiwan! - 40 Years Old Couple IVF Success Story

Considering their age, T-san and her husband decided to choose IVF as an efficient way to prepare for pregnancy as a 40 years old couple. NUWA Fertility Center along with our Japanese consultants became their first choice. Dr. Meng Shun Shen | NUWA Fertility Center Hello friends of Taiwan & Japan! T-san and her husband have been married for many years and wish for a baby. At 40, she has had several prenatal checkups and everything has worked out well, but she wanted to proceed with IVF due to the risks posed by age. They had a full Japanese consultation with the doctors and physicians at NUWA, so there was no language barrier. T-san’s husband is Taiwanese, so they were able to qualify for Taiwan’s IVF Aid Program. This program covers the process of egg retrieval, fertilization, a PGT-A (PGS) test for a superb embryo, and eventually successfully birthing a healthy baby boy at the end of 2022. "The couple came in months ago to say hi to me with their month-old baby, and even under their masks, I could see their happiness and joy." - Dr. Shen said. Maybe their son was too cute, and maybe it was because their entire experience was comfortable and trusting, they’re already planning their second child! I guess we’ll see each other soon. Meet the Qualifications and Enjoy Taiwan’s IVF Subsidy Program Taiwan’s IVF Aid Program has already been in effect for a year, and there already have been 50,000 couples who qualified for it. As long as you meet the qualifications and have Taiwanese citizenship, you’re able to apply for it. The biggest age range is 37 to 40-year-olds. In addition, while undergoing IVF, the chances of a healthy embryo successfully implanting significantly increase if there are PGS testings and a time-lapse system for embryos! Visit the largest fertility chain in Taiwan:https://www.nuwacare.com/en/ Follow Us on Facebook: https://www.facebook.com/NUWAFertilityCenter Contact us for consultation:ivfconsult@nuwacare.com

#Assisted Reproductive Technology
#Robotic Surgery
Successful Experience in Cell Therapy at CMUH Promoted to Malaysia, Taiwan and Malaysia Neurosurgical Societies Sign MOU to Enhance Medical and Health Cooperation
Successful Experience in Cell Therapy at CMUH Promoted to Malaysia, Taiwan and Malaysia Neurosurgical Societies Sign MOU to Enhance Medical and Health Cooperation

Successful Experience in Cell Therapy at CMUH Promoted to Malaysiao:p>/o:p> Taiwan and Malaysia Neurosurgical Societies Sign MOU to Enhance Medical and Health Cooperationo:p>/o:p> China Medical University Hospital(CMUH, Taiwan) has achieved notable success in cell therapy. Ms. Lin, who was diagnosed with malignant glioma, underwent tumor removal surgery, followed by radiation therapy and dendritic cell immunotherapy. After four years of monitoring, her condition remains stable, and she maintains a good quality of life. Dr. Chen Chun-Chung, Director of Neurosurgery, stated that this is a highly difficult-to-treat malignant tumor. The patient's positive attitude, combined with advanced cell therapy, has yielded impressive results, which is very encouraging. Neurosurgery is a strong suit and specialty of Chung Shan Medical University Affiliated Hospital. Advanced medical technologies first benefit domestic patients before expanding internationally. On September 14, three physicians from the China Medical University(CMU) healthcare system were invited to speak at the “Sarawak Neurosurgery Update & Neurosurgical Association of Malaysia Annual Scientific Meeting 2024. (NAM-SNU ASM 2024)” Dr. Chen Chun-Chung shared successful experiences in cell therapy, and the Taiwanese and Malaysian Neurosurgical Societies signed an MOU to strengthen medical exchange and cooperation.o:p>/o:p> Chief Chen Chun-Chung of the of Neurosurgery Department at CMUH (right) represented the Taiwan Neurosurgical Society to sign a MOU with Prof. Dato Dr. Abdul Rahman Izaini Ghani, President of the Neurosurgical Association of Malaysia, o:p>/o:p>in Kuching, Malaysia. This marks a new milestone in neurosurgical exchanges and cooperation between Taiwan and Malaysia. Moving forward, it will allow neurosurgeons in hospitals across Malaysia to gain comprehensive insights into Taiwan's advanced medical technologies, promoting significant benefits under the New Southbound Policy and showcasing Taiwan to the world.o:p>/o:p> Taiwan's First Participation in the NAM-SNU ASM: MOU Signed with Malaysian Society, Highlighting New Southbound Policyo:p>/o:p> Following the “Taiwan-Malaysia Neurosurgery Advanced Medical Summit 2024” organized by the Taiwan Neurosurgical Society in July of this year, Dr. Chen Chun-Chung, Director of Neurosurgery, Dr. Brian Chiu Cheng-Di, Director of Minimally Invasive Spine Neurosurgery (Deputy Director of the Spine Center), and Dr. Chuang Hao-Yu, Director of the Cell Therapy Center at Tainan City An Nan Hospital (Neurosurgery Director), were invited to the " NAM-SNU ASM 2024". This is the first time Taiwanese physicians have participated in this conference. The Taiwan Neurosurgical Society(TNS) and the Neurosurgical Association of Malaysia(NAM) signed a memorandum of understanding (MOU) at the conference, marking a significant highlight in the advancement of Taiwan-Malaysia neurosurgical research exchange.o:p>/o:p> Cutting-edge and Diverse Neurosurgical Techniques Attract Malaysian Physicians to Taiwan for Learningo:p>/o:p> At the conference, three physicians from CMU healthcare system shared their experiences in neurosurgery, including brain cancer, stroke, and endoscopic spine surgery. Their presentations garnered attention from the conference and participating physicians, leading to enthusiastic discussions.o:p>/o:p> Dr. Chen Chun-Chung shared that in 2000, Ms. Lin was diagnosed with malignant glioma after experiencing seizures. This type of brain cancer is challenging to manage. However, Ms. Lin was proactive and brave, with strong family support. After tumor removal surgery and radiation therapy, she underwent dendritic cell immunotherapy and completed a series of ten vaccine injections. Her condition has been monitored for over four years, showing good results. Dr. Chen noted that historically, after surgery for malignant gliomas, only radiation therapy and 1-2 types of targeted treatments were available, making treatment very difficult. The average survival rate post-treatment was 15 months, while the average at their hospital is 23 months, and Ms. Lin has exceeded four years. The hospital’s cell therapy has advanced to CAR-T cell therapy, continuously improving cancer treatment outcomes. They are pleased to share Taiwan's clinical experience in cell therapy with Malaysia to promote the exchange of new medical knowledge.o:p>/o:p> Dr. Brian Chiu Cheng-Di discussed Taiwan's extensive clinical experience in endoscopic spine surgery. This technique can be used for full-spine disc removal and degenerative spinal stenosis decompression, as well as fusion, infection, and tumor surgeries. With enhanced imaging and endoscopic views, surgeons can target areas typically obscured in traditional surgery, reducing surgical risks and offering benefits like smaller wounds and faster recovery. However, more rigorous evaluation is needed for cases with structural abnormalities, large lesions, multiple segments, malignancy, or bleeding tendencies. Dr. Qiu’s compelling presentation led three Malaysian experts to sign up to visit Chung Shan Medical University for learning.o:p>/o:p> Dr. Chuang Hao-Yu shared two experiences from Taiwan. First, intracerebral hemorrhagic stroke in Asia has a higher incidence compared to Western societies, with higher mortality and disability rates, leading to medical, family, and societal issues. The presentation included results from using a complex surgical system and a locally developed robotic surgical navigation system for precise minimally invasive intracerebral clot aspiration, which significantly reduced mortality and effectively lowered neurological disability compared to traditional open surgeries. Second, he shared the development of interventional vascular treatment in Taiwan. Efforts by six major related medical societies have successfully integrated clinical practice, certification training, and accreditation systems, and this experience was also shared with Malaysia.o:p>/o:p>Brain Navi Biotechnology and EPED Inc., also participated in the exhibition. The MOU signed between the TNS and the NAM will enable neurosurgeons across Malaysia to learn about Taiwan's advanced medical technologies, significantly advancing the New Southbound Policy and showcasing Taiwan to the world. Chief Chen Chun-Chung (right 8) of the of Neurosurgery Department at CMUH represented the Taiwan Neurosurgical Society to sign a MOU with Prof. Dato Dr. Abdul Rahman Izaini Ghani (right 9), President of the Neurosurgical Association of Malaysia, in Kuching, Malaysia. This marks a new milestone in neurosurgical exchanges and cooperation between Taiwan and Malaysia. Moving forward, it will allow neurosurgeons in hospitals across Malaysia to gain comprehensive insights into Taiwan's advanced medical technologies, promoting significant benefits under the New Southbound Policy and showcasing Taiwan to the world.o:p>/o:p> o:p>/o:p>
【NUWA】First Attempt Success After Blocked Fallopian Tubes
【NUWA】First Attempt Success After Blocked Fallopian Tubes

There was a girl from Macau who dreamed of becoming a mother but encountered blocked fallopian tubes. Undeterred, she bravely embarked on a journey to Taiwan, seeking help from NUWA Fertility Center in Taoyuan. Dr. Horng Shang Gwo | NUWA Fertility Center Good news from Macau before the Lunar New Year This patient from Macau came to NUWA Fertility Center in Taoyuan over a year ago. Her hysterosalpingography (HSG) suggested blocked fallopian tubes, and even after undergoing laparoscopic surgery, her tubes remained obstructed. Thus, she began her IVF journey and underwent PGS (preimplantation genetic screening). A single embryo was successfully implanted, and she graduated from NUWA with a confirmed pregnancy! Throughout her pregnancy, we kept in touch, and recently, she gave birth at full term, with both mother and baby doing well. Congratulations! Welcoming couples facing difficulties conceiving to have a consultation I’m delighted to share this wonderful news and spread the joy. For couples struggling with their fertility journey, feel free to come and talk with me. I will do my best to assist you, and together, we can look forward to welcoming your little bundle of joy! Visit the largest fertility chain in Taiwan:https://www.nuwacare.com/en/ Follow Us on Facebook: https://www.facebook.com/NUWAFertilityCenter Contact us for consultation:ivfconsult@nuwacare.com

#Assisted Reproductive Technology
W Story: Lovley twins came visit Dr. Hsieh
W Story: Lovley twins came visit Dr. Hsieh

On Saturday morning, a pair of lovely twins came visit Dr. Hsieh. They were born just 1 minute apart. Patients said that she never thought she would need IVF to help her achieve their dream to become parents since all the hormone level showed normal. They didn’t take it seriously when friends with IVF experience told them that “it would be more efficient to do IVF”o:p>/o:p> They've tried several rounds of oral ovulation pills and artificial insemination (IUI). o:p>/o:p> They decided to go for IVF after several failed rounds of IUI.o:p>/o:p> They remember vividly that their number of eggs collected during 1st egg retrieval was not as expected and she had emotional breakdown just after she recover in the operating room. However, she was very grateful to the team for giving "just enough" care in a timely manner. She said that the moment was "really, really, really needed."o:p>/o:p> They hang tight and when it comes to their second egg retrieval, the number of matured egg, the fertilization and blastocyst formation rates were much better than the first time. The second embryo transfer resulted in a successful pregnancy, and they were so excited when the doctor told them that he saw the fetal heartbeats. They had not thought about the huge challenges in life - until the day the twins were officially born. o:p>/o:p>

#Assisted Reproductive Technology
W Story: Twins safely landed on the Earth!
W Story: Twins safely landed on the Earth!

Dear Dr. Wang, My husband and I have no words to express our gratitude to you and your team. We, as a couple, had dreamed of having our own children for years, but we encountered so many obstacles and failures over the past years that we both felt frustrated and wanted to give up. Thanks to Dr. Wang for your professional knowledge and selfless dedication, you and your team helped us get pregnant smoothly and welcomed our twins on April 29. We know this process was not easy, but your patience and expertise made our dream come true.o:p>/o:p> Once again, I would like to sincerely thank Dr. Wang for being the angel in our lives. We will always remember your kindness!o:p>/o:p> And I hope Dr. Wang continue to help more families in need and realize their dreams to become parents! o:p>/o:p> July, 20 2024

#Assisted Reproductive Technology